Cardiac biomarkers in children with congenital heart disease (Q38603770)

4 September 2017

title

Cardiac biomarkers in children with congenital heart disease (English)

1 reference

4 September 2017

0 references

0 references

Masaya Sugimoto

1 reference

4 September 2017

Seiko Kuwata

1 reference

4 September 2017

Clara Kurishima

1 reference

4 September 2017

Jeong Hye Kim

1 reference

4 September 2017

Yoich Iwamoto

1 reference

4 September 2017

Hideaki Senzaki

1 reference

4 September 2017

publication date

11 October 2015

1 reference

World Journal of Pediatrics

4 September 2017

published in

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

309-315

1 reference

Role of the renin-angiotensin system in cardiac hypertrophy

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Angiotensin II, adhesion, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Limiting fibrosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Acute myocardial infarction: the enduring challenge for cardiac protection and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Troponin-I as a prognosticator of mortality in severe sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Myocardial dysfunction in pediatric septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Differential diagnosis of elevated troponins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Cardiac troponin I in congenital heart defects with pressure or volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

B-type natriuretic peptide in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Normal values of B type natriuretic peptide in infants, children, and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Effect of renal function loss on NT-proBNP level variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

B-type natriuretic peptide in paediatric patients with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

B-type natriuretic peptide: perioperative patterns in congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Plasma B-Type Natriuretic Peptides in Children With Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Biological serum markers in the management of pediatric pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Recommendations for the use of cardiac troponin measurement in acute cardiac care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12519-015-0039-X

Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis

21 January 2018

1 reference

12 December 2020

High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease

1 reference

12 December 2020

Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation

1 reference

12 December 2020

Grading the severity of congestive heart failure in infants

1 reference

12 December 2020

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

12 December 2020

Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction

1 reference

12 December 2020

Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot

1 reference

12 December 2020

Volume overload and pressure overload due to left-to-right shunt-induced myocardial injury. - Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease-

1 reference

12 December 2020

1 reference

12 December 2020

Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations

1 reference

12 December 2020

The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction

1 reference

12 December 2020

Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease

1 reference

12 December 2020

10.1007/S12519-015-0039-X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1008867005

0 references

1 reference